
- Volume 0 0
ORAL CORTICOSTEROID THERAPY MAY INCREASE INR
A potential drug interaction existsbetween oral corticosteroids and warfarin,but there is limited evidence todocument it. A recent retrospectivereview of 387 medical records ofpatients followed in an anticoagulationclinic demonstrated an increase ininternational normalized ratio (INR) inthe majority of patients who had corticosteroidsadded to their warfarintherapy. Patients were included in thestudy if they were stable on warfarintherapy and were prescribed a shorttermcourse of corticosteroids. Theywere excluded if they were prescribedan antibiotic or any other medicationthat had a probable interaction withwarfarin at the same time the corticosteroidswere started. Thirty-two patientsmet the criteria. The primary outcomeassessed was the difference betweenpre-and poststeroid INR values.Secondary end points included bleedingevents, emergency department visits,hospitalizations, and warfarin dosemodifications. Ninety-seven percent ofthe 32 patients studied had changes intheir poststeroid INR value, 62.5% ofwhich were supratherapeutic. The INRchange was observed most commonlyafter 6 to 7 days of corticosteroid therapy.Overall, 16 patients required amodification of their anticoagulationtherapy.
Dr. Garrett is a clinical pharmacist practitioner at Cornerstone Health Carein High Point, NC.
Articles in this issue
over 18 years ago
can you READ these Rxs?over 18 years ago
compounding HOTLINEover 18 years ago
Pseudoephedrine Logs Need Constant Tendingover 18 years ago
Another Federal Court Rejects a Drug Importation Planover 18 years ago
Home Infusion Therapy Gets Patients Out of the Hospitalover 18 years ago
RESPy AWARD: Teamwork Is the Thread That Bindsover 18 years ago
Child-resistant Does Not Mean Childproofover 18 years ago
ccpa SPEAKS OUT: CCPA Works to Improve Medicare Part Dover 18 years ago
Genetic Testing: Remarkable Resource or Invasion of Privacy?over 18 years ago
case STUDIESNewsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

















































































































































































































